Vertex Pharmaceuticals (VRTX)

EBITDA Growth

8.24%

Quarterly · Period ending:

VRTX logo

VRTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported8.24%
VRTX Quarterly EBITDA YoY % (60.00% → 8.24%)
High-resolution chart · PNG

VRTX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals EBITDA Growth — Quarterly
Period endingEBITDA Growth
8.2412%
67.4085%
17.359%
5.5495%
140.2248%
-41.787%
-2.6947%
4.2688%
-374.0549%
42.6144%
8.0227%
0.4402%
12.8031%
-6.3544%
22.5006%
8.596%
41,296.1538%
16.1909%
-1.545%
43.6593%
-99.6995%
23.906%
30.2195%
608.0514%
134.082%
92.8611%
1,178.9771%
-32.2162%
51.0374%
49.6076%
-60.334%
142.188%
276.2004%
-15.103%
151.6567%
-8,879.6763%
280.5346%
10,186.7244%
241.7409%
92.1626%
111.0324%
101.7446%
71.8977%
57.2985%
14.3025%
20.4747%
65.7075%
-18.2187%
-289.6802%
53.4024%
-533.8181%
-1,430.202%
-2,971.2111%
-526.3623%
-127.8633%
-96.1851%
99.0892%
164.7835%
215.6328%
207.9318%
2.1719%
-2.1847%
-55.9549%
-41.9101%
-14.333%
6.1615%
1.8747%
-15.4807%
-80.5571%
-78.6741%
-56.6834%
-14.8117%
30.3058%
-17.2874%
-210.8205%
-93.6507%
-63.7655%
-68.8996%
-106.2409%
-61.6442%
-86.4701%
-35.9419%
34.6447%
-26.3535%
-16.5585%
-21.8837%
80.3871%
68.54%
59.393%
-243.7311%
-287.8105%
-191.1677%
-359.5379%
192.421%
-254.4428%
-113.0311%
-23.3234%
-61.4434%
36.446%
-6.8907%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.